179 related articles for article (PubMed ID: 24104395)
1. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.
Canner J; Alonzo TA; Franklin J; Freyer DR; Gamis A; Gerbing RB; Lange BJ; Meshinchi S; Woods WG; Perentesis J; Horan J
Cancer; 2013 Dec; 119(23):4162-9. PubMed ID: 24104395
[TBL] [Abstract][Full Text] [Related]
2. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.
Woods WG; Franklin AR; Alonzo TA; Gerbing RB; Donohue KA; Othus M; Horan J; Appelbaum FR; Estey EH; Bloomfield CD; Larson RA
Cancer; 2013 Dec; 119(23):4170-9. PubMed ID: 24104597
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia.
Mizuno S; Takami A; Kawamura K; Arai Y; Kondo T; Kawata T; Uchida N; Marumo A; Fukuda T; Tanaka M; Ozawa Y; Yoshida S; Ota S; Takada S; Sawa M; Onizuka M; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):314.e1-314.e10. PubMed ID: 33836873
[TBL] [Abstract][Full Text] [Related]
4. Adolescents and young adult acute myeloid leukemia outcomes at pediatric versus adult centers: A population-based study.
Gupta S; Baxter NN; Sutradhar R; Pole JD; Nagamuthu C; Lau C; Nathan PC
Pediatr Blood Cancer; 2021 Aug; 68(8):e28939. PubMed ID: 33559361
[TBL] [Abstract][Full Text] [Related]
5. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
[No Abstract] [Full Text] [Related]
6. Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232.
Burke MJ; Devidas M; Chen Z; Salzer WL; Raetz EA; Rabin KR; Heerema NA; Carroll AJ; Gastier-Foster JM; Borowitz MJ; Wood BL; Winick NJ; Carroll WL; Hunger SP; Loh ML; Larsen EC
Leukemia; 2022 Mar; 36(3):648-655. PubMed ID: 34725453
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
[TBL] [Abstract][Full Text] [Related]
8. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
Tomizawa D; Watanabe T; Hanada R; Horibe K; Horikoshi Y; Iwamoto S; Kinoshita A; Moritake H; Nakayama H; Shimada A; Taga T; Takahashi H; Tawa A; Terui K; Hori H; Kawano Y; Kikuta A; Manabe A; Adachi S
Int J Hematol; 2015 Sep; 102(3):318-26. PubMed ID: 26126642
[TBL] [Abstract][Full Text] [Related]
9. Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).
Pemmaraju N; Kantarjian H; Ravandi F; Nogueras-Gonzalez GM; Huang X; O'Brien S; Wierda W; Garcia-Manero G; Thomas D; Pierce S; Verstovsek S; Borthakur G; Cortes J
Clin Lymphoma Myeloma Leuk; 2016 Apr; 16(4):213-222.e2. PubMed ID: 26838606
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia.
Tomizawa D; Tanaka S; Kondo T; Hashii Y; Arai Y; Kudo K; Taga T; Fukuda T; Goto H; Inagaki J; Koh K; Ohashi K; Ozawa Y; Inoue M; Kato K; Tanaka J; Atsuta Y; Adachi S; Ishida H
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1515-1522. PubMed ID: 28501543
[TBL] [Abstract][Full Text] [Related]
11. Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group.
Klein K; van Litsenburg RRL; de Haas V; Dors N; van den Heuvel-Eibrink MM; Knops RRG; Tissing WJE; Versluys BA; Zwaan CM; Kaspers GJL
Pediatr Blood Cancer; 2020 Apr; 67(4):e28099. PubMed ID: 31872548
[TBL] [Abstract][Full Text] [Related]
12. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
Barbaric D; Alonzo TA; Gerbing RB; Meshinchi S; Heerema NA; Barnard DR; Lange BJ; Woods WG; Arceci RJ; Smith FO
Blood; 2007 Mar; 109(6):2314-21. PubMed ID: 17158236
[TBL] [Abstract][Full Text] [Related]
13. Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Sorrell AD; Alonzo TA; Hilden JM; Gerbing RB; Loew TW; Hathaway L; Barnard D; Taub JW; Ravindranath Y; Smith FO; Arceci RJ; Woods WG; Gamis AS
Cancer; 2012 Oct; 118(19):4806-14. PubMed ID: 22392565
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis.
Berkman AM; Andersen CR; Cuglievan B; McCall DC; Lupo PJ; Parsons SK; DiNardo CD; Short NJ; Jain N; Kadia TM; Livingston JA; Roth ME
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1176-1184. PubMed ID: 35553621
[TBL] [Abstract][Full Text] [Related]
16. Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group.
Phillips CL; Lane A; Gerbing RB; Alonzo TA; Wilkey A; Radloff G; Lange B; Gamazon ER; Dolan ME; Davies SM
Clin Cancer Res; 2020 Jun; 26(12):2891-2897. PubMed ID: 32122921
[TBL] [Abstract][Full Text] [Related]
17. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Cooper TM; Franklin J; Gerbing RB; Alonzo TA; Hurwitz C; Raimondi SC; Hirsch B; Smith FO; Mathew P; Arceci RJ; Feusner J; Iannone R; Lavey RS; Meshinchi S; Gamis A
Cancer; 2012 Feb; 118(3):761-9. PubMed ID: 21766293
[TBL] [Abstract][Full Text] [Related]
18. Survival of childhood and adolescent/young adult (AYA) cancer patients in Ireland during 1994-2013: comparisons by age.
Alken S; Owens C; Gilham C; Grant C; Pears J; Deady S; O'Marcaigh A; Capra M; O'Mahony D; Smith O; Walsh PM
Ir J Med Sci; 2020 Nov; 189(4):1223-1236. PubMed ID: 32424602
[TBL] [Abstract][Full Text] [Related]
19. Effects of malnutrition on treatment-related morbidity and survival of children with cancer in Nicaragua.
Pribnow AK; Ortiz R; Báez LF; Mendieta L; Luna-Fineman S
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449403
[TBL] [Abstract][Full Text] [Related]
20. Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Tarlock K; Alonzo TA; Gerbing RB; Raimondi SC; Hirsch BA; Sung L; Pollard JA; Aplenc R; Loken MR; Gamis AS; Meshinchi S
Clin Cancer Res; 2016 Apr; 22(8):1951-7. PubMed ID: 26644412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
